PROMOMED DM LLC has successfully placed the second issue of exchange-traded bonds worth 1.5 billion rubles

PROMOMED DM LLC has successfully closed the book of applications for the second issue of exchange-traded bonds. Due to the high interest of investors, the issue volume was increased from 1 to 1.5 billion rubles, and the coupon rate was reduced from the initial range of 9.5-9.7% to 9.45% per annum. Both retail and institutional investors participated in the placement.

The nominal value of one bond is 1,000 rubles. The placement price is 100% of the face value. The circulation period is 3 years. The coupon period is 182 days. The placement method is an open subscription. The placement will take place on the Moscow Stock Exchange, the Third level of listing is expected. The issue meets the requirements for investing pension savings and insurance reserves.
The company invests the funds received from the bond placement in the development and production of active pharmaceutical substances and ready-made dosage forms, as well as the construction of new research laboratories and workshops. In the near future, PROMOMED plans to focus on expanding its portfolio by creating innovative antiviral, antibacterial, endocrinological and oncological drugs.

"The pharmaceutical industry is currently at the peak of investor interest, but only a few companies in the sector are represented on the open debt market, which requires maintaining business dynamics and transparency. We are pleased that Promomed meets the expectations of investors, and we plan to strengthen the company's investment attractiveness," commented Peter Bely, Chairman of the Board of Directors of Promomed Group.
The successful placement of the debut issue of PROMOMED DM LLC's 001P-01 exchange-traded bonds on the Moscow Stock Exchange took place on December 24, 2020, at which time the company raised 1 billion rubles at a rate of 9.5% per annum.
PROMOMED DM LLC's 001P-01 exchange-traded bonds are included in the listing of the Innovation and Investment Market sector of the Moscow Stock Exchange, which makes them more attractive to a wide range of investors, exempting them from personal income tax.

In June 2021, PROMOMED DM LLC paid the first coupon income on exchange-traded bonds on time and in full, with payments amounting to 47.37 million rubles.